health biotech news today obesity drugs glp-1 What is the pipeline for future medications for obesity? GLP-1 Market Trends and Global

No long-term safety data beyond 16 weeks

Monitoring thyroid function through TSH and free T3 testing helps identify whether thyroid supplementation might benefit users experiencing persistent fatigue or metabolic slowdown despite appropriate tirzepatide dosing

The risk of seizure is higher in people who take higher doses of CONTRAVE, have certain medical conditions, or take CONTRAVE with certain other medicines

[oai_citation:6PubMed]( [oai_citation:7PMC]( 5) Gastroprotective/cytoprotective actions in rodent models Multiple rat studies describe protection/healing in NSAID-induced and other gastric ulcer paradigms, consistent with mucosal cytoprotection concepts

Even 3 months of an exercise training program can increase circulating markers of bone formation in postmenopausal women [5]